Concepedia

Lidija Beketić-Orešković

LB

Statistics

Publications

10

Citations

506

H-Index

10

Active since

1993

Affiliations

University of Zagreb(Current)

Ruđer Bošković Institute

University Hospital Centre Zagreb

Stanford University

Lidija Beketić-Orešković is an author at University of Zagreb specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1993–2017

10

Publications

10

Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).

Charles Dumontet, George E. Durán, Kathleen A. Steger et al. · PubMed · 1996 · 112 citations

, , +15

Decreased Mutation Rate for Cellular Resistance to Doxorubicin and Suppression of mdrl Gene Activation by the Cyclosporin PSC 833

Lidija Beketić-Orešković, George E. Durán, Kevin G. Chen et al. · JNCI Journal of the National Cancer Institute · 1995 · 84 citations

, , +16

Tumor markers in breast cancer--evaluation of their clinical usefulness.

Petra Marić, Petar Ozretić, Sonja Levanat et al. · PubMed · 2011 · 79 citations · Full text

, , +12

A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma

Stjepan Orešković, Damir Babić, Držislav Kalafatić et al. · Gynecologic Oncology · 2004 · 64 citations

, , +14

Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients

Petar Ozretić, Ilija Alvir, Božena Šarčević et al. · The International Journal of Biological Markers · 2017 · 43 citations · Full text

, , +17

1–5 of 10